Fritextsökning
Innehållstyper
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Diagnostics to deal with new diseases
Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...
-
Irras har rekryterat ny IR-ansvarig
Sten Gustafsson blir chef för Investor Relations.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
”Danmark starkare i klassisk kapitalfinansiering”
Små life science-företag i Sverige har svårt med att hitta finansiering och kompetens.
-
Bayers njurläkemedel får grönt ljus i Europa
EMA har godkänt Bayers läkemedel mot kronisk njursjukdom i kombination med typ 2-diabetes. "Godkännandet av finerenon i Europa är goda nyheter som ger ytterliga...
-
Immunterapibolag tar in 339 miljoner
Immunterapibolaget Asgard Therapeutics har tagit in 30 miljoner euro, motsvarande omkring 339 miljoner kronor, i en finanseringsrunda.
-
Elekta i trepartssamarbete om precisionsmedicin
Medtech-företaget Elekta har ingått ett samarbete med Karolinska universitetssjukhuset och Karolinska institutet.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...
-
Ny HR-direktör till Medicover
Med erfarenhet från flera globala företag kliver hon in i ledningsgruppen.
-
Vd-posten på Atlas Antibodies är hennes
Bioteknikbolaget Atlas Antibodies har utsett Ingela Hofverberg till permanent vd.
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Här är covidvaccinen som är på väg – Novavax vaccin kan godkännas redan i år
Flera olika sorters vaccin mot covid-19 utvärderas nu av den europeiska läkemedelsmyndigheten EMA. Novavax vaccin Nuvaxovid kan komma att godkännas redan nästa månad.
-
Hitflyttade ska sälja Sverige
Internationella nyckelpersoner hyllar Sverige som life science-nation i slutfasen av EMA-striden.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Uppsala startar antibiotikacentrum
Ska bli ett kunskapscentrum med utbildning av forskare inom antibiotikaresistens.
BREAKING